HK1137186A1 - Consensus peptide - Google Patents

Consensus peptide

Info

Publication number
HK1137186A1
HK1137186A1 HK10104769.9A HK10104769A HK1137186A1 HK 1137186 A1 HK1137186 A1 HK 1137186A1 HK 10104769 A HK10104769 A HK 10104769A HK 1137186 A1 HK1137186 A1 HK 1137186A1
Authority
HK
Hong Kong
Prior art keywords
consensus peptide
biomineralization
mineralization
stimulation
induction
Prior art date
Application number
HK10104769.9A
Other languages
English (en)
Inventor
Stale Petter Lyngstadaas
Jan Eirik Ellingsen
Original Assignee
Corticalis As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corticalis As filed Critical Corticalis As
Publication of HK1137186A1 publication Critical patent/HK1137186A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14Peptides being immobilised on, or in, an inorganic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Dental Preparations (AREA)
HK10104769.9A 2006-12-21 2010-05-14 Consensus peptide HK1137186A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87614906P 2006-12-21 2006-12-21
PCT/IB2007/004068 WO2008078167A2 (en) 2006-12-21 2007-12-21 Consensus peptide

Publications (1)

Publication Number Publication Date
HK1137186A1 true HK1137186A1 (en) 2010-07-23

Family

ID=39387381

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104769.9A HK1137186A1 (en) 2006-12-21 2010-05-14 Consensus peptide

Country Status (13)

Country Link
US (1) US8367602B2 (ko)
EP (1) EP2118136B1 (ko)
JP (1) JP5253412B2 (ko)
KR (2) KR101493437B1 (ko)
AT (1) ATE475670T1 (ko)
AU (1) AU2007337797B2 (ko)
CA (1) CA2673382C (ko)
DE (1) DE602007008147D1 (ko)
DK (1) DK2118136T3 (ko)
ES (1) ES2349889T3 (ko)
HK (1) HK1137186A1 (ko)
PL (1) PL2118136T3 (ko)
WO (1) WO2008078167A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011111832A1 (ja) * 2010-03-11 2011-09-15 独立行政法人理化学研究所 ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用
SE537635C2 (sv) 2012-09-18 2015-08-25 Corticalis As Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden
EP4125993A4 (en) * 2020-03-26 2024-04-24 Bone Sci. Bio Ltd. PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108947A0 (en) * 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US7132015B2 (en) * 2002-02-20 2006-11-07 University Of Southern California Materials for dental and biomedical application
EP1830863A2 (en) * 2004-12-10 2007-09-12 Straumann Holding AG Protein formulation
WO2006126595A1 (ja) * 2005-05-27 2006-11-30 Japan Science And Technology Agency 機能性材料の三次元構造体

Also Published As

Publication number Publication date
CA2673382A1 (en) 2008-07-03
DE602007008147D1 (de) 2010-09-09
WO2008078167A2 (en) 2008-07-03
EP2118136B1 (en) 2010-07-28
EP2118136A2 (en) 2009-11-18
DK2118136T3 (da) 2010-11-15
JP2010513460A (ja) 2010-04-30
WO2008078167A3 (en) 2008-08-21
KR20150014999A (ko) 2015-02-09
JP5253412B2 (ja) 2013-07-31
PL2118136T3 (pl) 2011-04-29
US8367602B2 (en) 2013-02-05
CA2673382C (en) 2016-03-29
KR20090117702A (ko) 2009-11-12
AU2007337797A1 (en) 2008-07-03
KR101493437B1 (ko) 2015-02-16
AU2007337797B2 (en) 2012-08-23
ES2349889T3 (es) 2011-01-12
US20100172949A1 (en) 2010-07-08
ATE475670T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
TN2012000303A1 (en) Oxyntomodulin peptide analogue
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
TN2012000302A1 (en) Oxyntomodulin peptide analogue
IN2012DN03310A (ko)
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
MX346450B (es) Composiciones y métodos para el tratamiento de la enfermedad celíaca.
LT2506857T (lt) Mrnr tiekimas baltymų ir fermentų papildymui žmogaus genetinių ligų atvejais
MX2019011592A (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
UA94221C2 (en) Lipocalin protein
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MX2010005651A (es) Inhibicion de receptor de proteina de estimulacion de macrofagos (ron) y sus metodos de tratamiento.
ZA200900379B (en) Human endogenous retrovirus polypeptide compositions and methods of use thereof
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MX2012001346A (es) Polipeptidos del factor ix modificados y usos de los mismos.
HK1127910A1 (en) Compositions containing peptides with non-natural amino acids and methods of use
TN2009000135A1 (en) Use of modified cyclosporins
HK1137186A1 (en) Consensus peptide
EP2294197A4 (en) HHIP1 PROTEIN VERSION AND METHOD AND USES THEREOF
WO2009132231A8 (en) Peptidyl diacylglycerides
EP2229446A4 (en) HYDROGENASE POLYPEPTIDE AND USE METHOD
MX2010005280A (es) Nuevos peptidos sinteticos sustituidos con arginina y su uso.